It was shown that non-typical immune checkpoint regulator interleukin-1 receptor 8 (IL-1R8) can regulate anti-tumor response via NK-cell mediated resistance to hepatic carcinogenesis and hematogenous liver and lung metastasis [117]. This evidence concerns the gene IL1RAPL1 and neoplasm.